{"id":94043,"date":"2005-05-20T06:00:00","date_gmt":"2005-05-20T04:00:00","guid":{"rendered":"https:\/\/mediarun.com\/index.php\/news-posts\/kolejne-zwyciestwo-peppermint-medical\/"},"modified":"2005-05-20T06:00:00","modified_gmt":"2005-05-20T04:00:00","slug":"kolejne-zwyciestwo-peppermint-medical","status":"publish","type":"post","link":"https:\/\/mediarun.com\/pl\/marketing\/atl\/kolejne-zwyciestwo-peppermint-medical.html","title":{"rendered":"Kolejne zwyci\u0119stwo Peppermint Medical"},"content":{"rendered":"<p><P>GlaxoSmithKline Healthcare Sp. z o.o. Przetarg rozstrzygni\u0119ty zosta\u0142 w kwietniu, a od pocz\u0105tku maja agencja prowadzi dzia\u0142ania.<\/P><br \/>\n<P>W ramach wygranego przetargu agencja Peppermint odpowiedzialna jest za strategi\u0119&nbsp; komunikacji marki, a tak\u017ce za przygotowanie i kreacj\u0119 materia\u0142\u00f3w POS. <\/P><br \/>\n<P>Solpadeine nale\u017cy do kategorii lek\u00f3w przeciwb\u00f3lowych dost\u0119pnych tylko w aptece, bez recepty. W ramach akcji dzia\u0142ania skierowane zostan\u0105 do farmaceut\u00f3w i lekarzy stomatolog\u00f3w. Materia\u0142y POS, jakie otrzymaj\u0105 specjali\u015bci maj\u0105 na celu podkre\u015blenie unikatowo\u015bci leku i szybko\u015bci dzia\u0142ania przeciwb\u00f3lowego.&nbsp; <\/P><br \/>\n<P>GlaxoSmithKline Consumer Healthcare jest jednym z kluczowych klient\u00f3w Peppermint Medical. Agencja wsp\u00f3\u0142pracuje z GSK w zakresie obs\u0142ugi marek: Magvit, Ketoprom, Stavomax oraz Benevit Optic.<\/P><\/p>\n","protected":false},"excerpt":{"rendered":"Peppermint Medical &#8211; Dzia\u0142 Medyczny agencji Peppermint wygra\u0142 przetarg na obs\u0142ug\u0119 Solpadeine &#8211; marki nale\u017c\u0105cej do portfolio produkt\u00f3w&#8230;","protected":false},"author":1,"featured_media":94044,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"csco_display_header_overlay":false,"csco_singular_sidebar":"","csco_page_header_type":"","csco_page_load_nextpost":"","csco_post_video_location":[],"csco_post_video_location_hash":"","csco_post_video_url":"","csco_post_video_bg_start_time":0,"csco_post_video_bg_end_time":0,"footnotes":""},"categories":[9642],"tags":[],"class_list":{"0":"post-94043","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-atl","8":"cs-entry","9":"cs-video-wrap"},"_links":{"self":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts\/94043","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/comments?post=94043"}],"version-history":[{"count":0,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts\/94043\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/media\/94044"}],"wp:attachment":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/media?parent=94043"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/categories?post=94043"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/tags?post=94043"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}